132 related articles for article (PubMed ID: 29300947)
1. Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine.
Giri S; Kumar N; Dhanapal P; Venkatesan J; Kasirajan A; Iturriza-Gomara M; John J; Abraham AM; Grassly NC; Kang G
J Infect Dis; 2018 Apr; 217(9):1395-1398. PubMed ID: 29300947
[TBL] [Abstract][Full Text] [Related]
2. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
4. The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.
Cardemil CV; Estivariz C; Shrestha L; Sherchand JB; Sharma A; Gary HE; Oberste MS; Weldon WC; Bowen MD; Vinjé J; Schluter WW; Anand A; Mach O; Chu SY
Vaccine; 2016 May; 34(22):2519-26. PubMed ID: 27085172
[TBL] [Abstract][Full Text] [Related]
5. The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial.
John J; Giri S; Karthikeyan AS; Lata D; Jeyapaul S; Rajan AK; Kumar N; Dhanapal P; Venkatesan J; Mani M; Hanusha J; Raman U; Moses PD; Abraham A; Bahl S; Bandyopadhyay AS; Ahmad M; Grassly NC; Kang G
J Infect Dis; 2017 Feb; 215(4):529-536. PubMed ID: 28003352
[TBL] [Abstract][Full Text] [Related]
6. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
Samoilovich E; Roivainen M; Titov LP; Hovi T
J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
[TBL] [Abstract][Full Text] [Related]
7. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
Ogra PL
Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
[TBL] [Abstract][Full Text] [Related]
8. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
[TBL] [Abstract][Full Text] [Related]
9. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
[TBL] [Abstract][Full Text] [Related]
10. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
[TBL] [Abstract][Full Text] [Related]
11. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
Ramsay ME; Begg NT; Gandhi J; Brown D
Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
[TBL] [Abstract][Full Text] [Related]
13. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
[TBL] [Abstract][Full Text] [Related]
14. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
[TBL] [Abstract][Full Text] [Related]
16. Monovalent type 1 oral poliovirus vaccine in newborns.
el-Sayed N; el-Gamal Y; Abbassy AA; Seoud I; Salama M; Kandeel A; Hossny E; Shawky A; Hussein HA; Pallansch MA; van der Avoort HG; Burton AH; Sreevatsava M; Malankar P; Wahdan MH; Sutter RW
N Engl J Med; 2008 Oct; 359(16):1655-65. PubMed ID: 18923170
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
[TBL] [Abstract][Full Text] [Related]
19. Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination.
Tan SK; Granados AC; Bouquet J; Hoy-Schulz YE; Green L; Federman S; Stryke D; Haggerty TD; Ley C; Yeh MT; Jannat K; Maldonado YA; Andino R; Parsonnet J; Chiu CY
Sci Rep; 2020 Sep; 10(1):15392. PubMed ID: 32958861
[TBL] [Abstract][Full Text] [Related]
20. Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
Halpern MS; Altamirano J; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S78-S84. PubMed ID: 30376083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
